Evidence-based insights into peptide protocols, safety research, and optimization strategies. Built on clinical rigor, powered by community knowledge.
Get weekly insights on peptide protocols, safety updates, and optimization strategies delivered to your inbox.
No spam. Unsubscribe anytime. Clinical rigor, always.
Deep dives into peptide science — evidence-graded, honestly reported
HPTA recovery after testosterone therapy takes far longer than forums claim. Established PCT has limits, and peptides offer a mechanistically compelling but clinically unproven layer on top.
Exogenous testosterone suppresses the hypothalamic-pituitary-testicular axis at every level. Recovery is measured in months to years, not weeks. This article maps the clinical timeline, examines where Kisspeptin-10, triptorelin, and GH secretagogues fit, and is honest about what the evidence does and does not support.
Comprehensive outcome research with safety data and practical protocol references
Detailed compound profiles with mechanisms, safety data, and dosing protocols
Evidence-based supplement stacks designed to support your peptide protocols
Two sister peptides from the same Cold War lab, one calms the emotional floor, the other raises the cognitive ceiling. The mechanistic case for stacking them is architecturally compelling. The clinical evidence for the combination doesn't exist yet.
Selank and Semax are sister heptapeptides engineered with the same glyproline stability tail but from opposite parent molecules, tuftsin (immune) and ACTH (stress). They converge on BDNF through completely different upstream pathways, covering complementary neurochemical territory. This article examines the mechanistic case for combining them, the cofactors that determine whether either signal lands, and where the evidence stops short.
The peptide revolution promises to rewire your brain — but your immune system might have other plans.
An evidence-based exploration of neuroprotective peptides including GLP-1 receptor agonists, Selank, and Dihexa. We examine clinical promise alongside immunogenicity risks, grey-market purity concerns, and the thin line between neuroregeneration and oncogenic overstimulation.
A four-amino-acid peptide that activates telomerase, remodels chromatin, and restores melatonin synthesis from the pineal gland — addressing five hallmarks of aging simultaneously. The Russian clinical data spans 12–15 years. Independent Western replication barely exists.
Epitalon (AEDG) is a synthetic tetrapeptide modeled after the bovine pineal extract Epithalamin. It upregulates hTERT to activate telomerase, remodels heterochromatin to re-access silenced genes, restores endogenous melatonin production (160% increase in clinical trials), and demonstrated a 28% decrease in overall mortality over a 12-year human follow-up. A 2025 study revealed selective ALT pathway activation in cancer cells. The compound remains investigational — nearly all positive data originates from a single institutional network in St. Petersburg, and independent Western replication is virtually absent.
An ACTH-derived heptapeptide that upregulates BDNF, modulates the Default Mode Network, and delivers 20-24 hours of neuroprotection per dose — without a single hormonal side effect.
Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) engineered from the ACTH(4-10) fragment. It upregulates Brain-Derived Neurotrophic Factor, inhibits enkephalinase, and suppresses neuroinflammation — delivering cognitive enhancement, stroke recovery support, and neuroprotection through a single intranasal molecule.
A tuftsin-derived heptapeptide that delivers benzodiazepine-level anxiety relief without sedation, dependence, or cognitive fog — while simultaneously boosting immune defence.
Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) engineered from the immune peptide tuftsin. It allosterically modulates GABA-A receptors, stabilises endogenous enkephalins, and upregulates BDNF — delivering anxiolysis, cognitive enhancement, and immunomodulation in a single molecule.
A three-amino-acid peptide that bypasses the blood-brain barrier, enters the nucleus, and directly modulates gene expression for neuroprotection.
Pinealon is a synthetic tripeptide bioregulator (Glu-Asp-Arg) that penetrates the blood-brain barrier and nuclear membrane to directly influence chromatin remodeling, serotonin synthesis, and antioxidant defense in neurons.
The biochemical cofactors your body needs to support Selank therapy.
Evidence-based supplement companion for Selank — a tuftsin-derived heptapeptide that delivers benzodiazepine-level anxiety relief without sedation, dependence, or cognitive fog — while simultaneously boosting immune defence.
35+
Articles
18
Categories